VC
Vivo Capital Portfolio holdings
AUM $977M
1-Year Return
209.68%
This Quarter Return
+19.66%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$755M
AUM Growth
-$138M
(-15%)
Cap. Flow
-$182M
Cap. Flow
% of AUM
-24.12%
Top 10 Holdings %
Top 10 Hldgs %
75.28%
Holding
43
New
3
Increased
4
Reduced
7
Closed
3
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
+$8.14M |
| 2 |
CMPS
Compass Pathways
CMPS
|
+$5.02M |
| 3 |
Oric Pharmaceuticals
ORIC
|
+$4.48M |
| 4 |
Surrozen
SRZN
|
+$3.03M |
| 5 |
89bio
ETNB
|
+$2.74M |
Top Sells
| 1 |
Soleno Therapeutics
SLNO
|
+$131M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$53.7M |
| 3 |
Delcath Systems
DCTH
|
+$12.2M |
| 4 |
RGLS
Regulus Therapeutics
RGLS
|
+$4.03M |
| 5 |
Rezolute
RZLT
|
+$1.99M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cogent Biosciences
COGT
$1.73B
| $6.72M | 0.89% |
1,122,471
| – | – |
|
27
Unicycive Therapeutics
UNCY
$71.4M
| $6.54M | 0.87% |
1,137,015
+140,000
| +14% | +$805K |
|
28
Celcuity
CELC
$2.32B
| $6.17M | 0.82% |
610,500
| – | – |
|
|
29
Rezolute
RZLT
$671M
| $6.13M | 0.81% |
2,112,432
-685,272
| -24% | -$1.99M |
|
30
Sera Prognostics
SERA
$122M
| $6.07M | 0.8% |
1,650,440
| – | – |
|
31
Olema Pharmaceuticals
OLMA
$532M
| $5.66M | 0.75% |
1,505,862
| – | – |
|
|
RGLS
32
DELISTED
Regulus Therapeutics
RGLS
| $4.72M | 0.62% |
2,696,426
-2,303,574
| -46% | -$4.03M |
|
|
SLN
33
Silence Therapeutics
SLN
$237M
| $3.12M | 0.41% |
1,105,454
| – | – |
|
|
34
Surrozen
SRZN
$99M
| $3.03M | 0.4% |
+260,000
| New | +$3.03M |
|
|
35
89bio
ETNB
$1.2B
| $2.74M | 0.36% |
+376,804
| New | +$2.74M |
|
36
Bolt Biotherapeutics
BOLT
$10.3M
| $1.41M | 0.19% |
176,065
| – | – |
|
37
Tenax Therapeutics
TENX
$28.5M
| $1.36M | 0.18% |
208,333
| – | – |
|
|
ALLK
38
DELISTED
Allakos
ALLK
| $174K | 0.02% |
765,500
-2,190,610
| -74% | -$499K |
|
39
Aligos Therapeutics
ALGS
$64.1M
| $84.1K | 0.01% |
10,199
-131,680
| -93% | -$1.09M |
|
40
Precision BioSciences
DTIL
$53.4M
| $22.3K | ﹤0.01% |
4,675
| – | – |
|
41
Corbus Pharmaceuticals
CRBP
$142M
| – | – |
-166,794
| Closed | -$1.97M |
|
|
DBVT
42
DBV Technologies
DBVT
$270M
| – | – |
-32,020
| Closed | -$98.9K |
|
43
Q32 Bio
QTTB
$21.8M
| – | – |
-20,559
| Closed | -$70.7K |
|